Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy

Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy

Moo-Yong Rhee,1 Sang Hong Baek,2 Weon Kim,3 Chang Gyu Park,4 Seung Woo Park,5 Byung-Hee Oh,6 Sang-Hyun Kim,7 Jae-Joong Kim,8 Joon-Han Shin,9 Byung-Su Yoo,10 Se-Joong Rim,11 Jong-Won Ha,12 Joon Hyung Doh,13 Youngkeun Ahn,14 Jei Keon Chae,15 Jeong Bae Park,16 Soon-Kil Kim,17 Cheol Ho Kim18 1...

Full description

Bibliographic Details
Main Authors:	Rhee MY, Baek SH, Kim W, Park CG, Park SW, Oh BH, Kim SH, Kim JJ, Shin JH, Yoo BS, Rim SJ, Ha JW, Doh JH, Ahn Y, Chae JK, Park JB, Kim SK, Kim CH
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-06-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/efficacy-of-fimasartanhydrochlorothiazide-combination-in-hypertensive--peer-reviewed-article-DDDT

Similar Items

Fimasartan for Remodeling after Myocardial Infarction
by: Byung-Kwan Lim, et al.
Published: (2019-03-01)

Fimasartan for independent reduction of blood pressure variability in mild-to-moderate hypertension
by: Shin MS, et al.
Published: (2016-05-01)

Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects
by: Kang WY, et al.
Published: (2018-10-01)

Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial
by: Min-gu Kang, et al.
Published: (2019-07-01)

The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan
by: Gu N, et al.
Published: (2016-04-01)

Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain
by: Chi Kyung Kim, et al.
Published: (2015-01-01)

Fimasartan: A new armament to fight hypertension
by: Akshyaya Pradhan, et al.
Published: (2019-01-01)

Gender-specific differences in the incidence of microalbuminuria in metabolic syndrome patients after treatment with fimasartan: The K-MetS study.
by: Jeong Bae Park, et al.
Published: (2017-01-01)

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians
by: Lee J, et al.
Published: (2018-04-01)

A Pharmacokinetic Drug Interaction Between Fimasartan and Linagliptin in Healthy Volunteers
by: Kang WY, et al.
Published: (2020-05-01)

Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers
by: Choi Y, et al.
Published: (2018-07-01)

Effect of renal function on the pharmacokinetics of fimasartan: a single-dose, open-label, Phase I study
by: Kim S, et al.
Published: (2014-10-01)

Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved In Situ Absorption Method in Rats
by: Tae Hwan Kim, et al.
Published: (2018-10-01)

Fimasartan reduces neointimal formation and inflammation after carotid arterial injury in apolipoprotein E knockout mice
by: Jong-Ho Kim, et al.
Published: (2019-07-01)

Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets
by: Hyeon Woo Moon, et al.
Published: (2014-06-01)

Effect of Fimasartan versus Valsartan and Olmesartan on Office and Ambulatory Blood Pressure in Korean Patients with Mild-to-Moderate Essential Hypertension: A Randomized, Double-Blind, Active Control, Three-Parallel Group, Forced Titration, Multicenter, Phase IV Study (Fimasartan Achieving Systolic Blood Pressure Target (FAST) Study)
by: Chung WB, et al.
Published: (2020-01-01)

Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of fimasartan, amlodipine, and rosuvastatin using partial replicated design in healthy adult subjects
by: Oh M, et al.
Published: (2018-05-01)

Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions
by: Yong-Jik Lee, et al.
Published: (2017-01-01)

Fimasartan reduces clinic and home pulse pressure in elderly hypertensive patients: A K-MetS study.
by: Eun Joo Cho, et al.
Published: (2019-01-01)

Effect of home blood pressure monitoring for blood pressure control in hypertensive patients taking multiple antihypertensive medications including fimasartan (the FORTE study)
by: Jung-Yeon Choi, et al.
Published: (2020-12-01)

Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure
by: Hailian Quan, et al.
Published: (2020-11-01)

FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial
by: Jang-Young Kim, et al.
Published: (2017-12-01)

P118 Arterial Stiffness in Patients with Arterial Hypertension on Short Term Dual Treatment with Fimasartan/Amlodipine
by: Brandon Giovany Illescas Vidrio, et al.
Published: (2020-02-01)

Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study
by: Oh GC, et al.
Published: (2020-04-01)

Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial
by: Dong Hoon Shin, et al.
Published: (2019-01-01)

Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II
by: Radhika G. Sojitra, et al.
Published: (2021-09-01)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
by: Ihm SH, et al.
Published: (2016-11-01)

Clinical features, treatment and outcomes of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma: literature reviews published in English between 1993 and 2017
by: Won JH, et al.
Published: (2019-09-01)

Short- and long-term outcomes of laparoscopic surgery vs open surgery for transverse colon cancer: a retrospective multicenter study
by: Kim JW, et al.
Published: (2016-04-01)

Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule
by: Gurunathan S, et al.
Published: (2015-04-01)

Comparative assessment of the apoptotic potential of silver nanoparticles synthesized by Bacillus tequilensis and Calocybe indica in MDA-MB-231 human breast cancer cells: targeting p53 for anticancer therapy
by: Gurunathan S, et al.
Published: (2015-06-01)

Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort
by: Kim SJ, et al.
Published: (2021-08-01)

Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD [Corrigendum]
by: Kang HS, et al.
Published: (2017-01-01)

Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD
by: Kang HS, et al.
Published: (2016-10-01)

Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorvastatin 40 mg versus Separate Tablets
by: Hwang JG, et al.
Published: (2020-05-01)

Clinical characteristics and satisfaction with the fimasartan in Korean hypertensive patients: a prospective, cross-sectional and open-label, 8-week switching study (Kanarb-hypertension epidemiology medication satisfaction study; K-HEMS study)
by: Dong Joo Oh, et al.
Published: (2018-09-01)

Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study
by: Nam Hoon Kim, et al.
Published: (2017-06-01)

Male current smokers have low awareness and optimistic bias about COPD: field survey results about COPD in Korea
by: Hwang YI, et al.
Published: (2019-01-01)

Ginkgo biloba: a natural reducing agent for the synthesis of cytocompatible graphene
by: Gurunathan S, et al.
Published: (2014-01-01)

Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications
by: Lee JH, et al.
Published: (2017-04-01)